1-8 of 8
Hiroaki Okuyama
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3229: Distinct types of cetuximab resistant KRAS mutant of colorectal cancer revealed by an integrated sensitivity assay

Takahiro Tashiro, Hiroaki Okuyama, Hiroko Endo, Kenji Kawada, Masayuki Ohue, Yoshiharu Sakai, Masahiro Inoue
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3229.
https://doi.org/10.1158/1538-7445.AM2015-3229
Published: 01 August 2015
View article titled, Abstract 3229: Distinct types of cetuximab resistant KRAS mutant of colorectal cancer revealed by an integrated sensitivity assay
Journal Articles

Abstract 1341: Rapid decrease of ATP followed by necrosis-like cell death in bladder cancer cells after exposure to high-dose chemotherapeutics used in intravesical therapy

Takahiro Yoshida, Hiroaki Okuyama, Masashi Nakayama, Kazuo Nishimura, Norio Nonomura, Masahiro Inoue
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1341.
https://doi.org/10.1158/1538-7445.AM2014-1341
Published: 01 October 2014
View article titled, Abstract 1341: Rapid decrease of ATP followed by necrosis-like cell death in bladder cancer cells after exposure to high-dose chemotherapeutics used in intravesical therapy
Journal Articles

Abstract 495: Inactive status of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia

Masahiro Inoue, Hiroaki Okuyama, Hiroko Endo, Masayuki Ohue
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 495.
https://doi.org/10.1158/1538-7445.AM2014-495
Published: 01 October 2014
View article titled, Abstract 495: Inactive status of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia
Journal Articles

Abstract 3832: Cancer tissue-derived spheroid, CTOS, for evaluation of drug response from individual patient tumor samples.

Masahiro Inoue, Hiroko Endo, Masayuki Ohue, Kazuo Nishimura, Fumio Imamura, Jiro Okami, Hiroaki Okuyama
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3832.
https://doi.org/10.1158/1538-7445.AM2013-3832
Published: 15 April 2013
View article titled, Abstract 3832: Cancer tissue-derived spheroid, CTOS, for evaluation of drug response from individual patient tumor samples.
Journal Articles

Downregulation of c-MYC Protein Levels Contributes to Cancer Cell Survival under Dual Deficiency of Oxygen and Glucose

Hiroaki Okuyama, Hiroko Endo, Tamaki Akashika, Kikuya Kato, Masahiro Inoue
Journal: Cancer Research
Cancer Res (2010) 70 (24): 10213–10223.
https://doi.org/10.1158/0008-5472.CAN-10-2720
Published: 14 December 2010
View article titled, Downregulation of c-MYC Protein Levels Contributes to Cancer Cell Survival under Dual Deficiency of Oxygen and Glucose
Open the PDF for Downregulation of c-MYC Protein Levels Contributes to Cancer Cell Survival under Dual Deficiency of Oxygen and Glucose in another window
Includes: Supplementary data
Journal Articles

Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells

Yi Fu Zhou, Marta Bosch-Marce, Hiroaki Okuyama, Balaji Krishnamachary, Hideo Kimura, Li Zhang, David L. Huso, Gregg L. Semenza
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10849–10854.
https://doi.org/10.1158/0008-5472.CAN-06-2146
Published: 15 November 2006
View article titled, Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
Open the PDF for Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells in another window
Journal Articles

Hypoxia-Inducible Factor-1-Dependent Repression of E-cadherin in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B

Balaji Krishnamachary, David Zagzag, Hideko Nagasawa, Karin Rainey, Hiroaki Okuyama, Jin H. Baek, Gregg L. Semenza
Journal: Cancer Research
Cancer Res (2006) 66 (5): 2725–2731.
https://doi.org/10.1158/0008-5472.CAN-05-3719
Published: 01 March 2006
View article titled, Hypoxia-Inducible Factor-1-Dependent Repression of <em>E-cadherin</em> in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B
Open the PDF for Hypoxia-Inducible Factor-1-Dependent Repression of <em>E-cadherin</em> in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B in another window
Journal Articles

Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor

David Zagzag, Balaji Krishnamachary, Herman Yee, Hiroaki Okuyama, Luis Chiriboga, M. Aktar Ali, Jonathan Melamed, Gregg L. Semenza
Journal: Cancer Research
Cancer Res (2005) 65 (14): 6178–6188.
https://doi.org/10.1158/0008-5472.CAN-04-4406
Published: 15 July 2005
View article titled, Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
Open the PDF for Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor in another window